X-ray structures of Sap1 and Sap5: structural comparison of the secreted aspartic proteinases from Candida albicans.
Détails
ID Serval
serval:BIB_4BA71B6B0855
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
X-ray structures of Sap1 and Sap5: structural comparison of the secreted aspartic proteinases from Candida albicans.
Périodique
Proteins
ISSN
1097-0134[electronic]
Statut éditorial
Publié
Date de publication
2008
Volume
72
Numéro
4
Pages
1308-1319
Langue
anglais
Résumé
Proteolytic activity is an important virulence factor for Candida albicans (C. albicans). It is attributed to the family of the secreted aspartic proteinases (Saps) from C. albicans with a minimum of 10 members. Saps show controlled expression and regulation for the individual stages of the infection process. Distinct isoenzymes can be responsible for adherence and tissue damage of local infections, while others cause systemic diseases. Earlier, only the structures of Sap2 and Sap3 were known. In our research, we have now succeeded in solving the X-ray crystal structures of the apoenzyme of Sap1 and Sap5 in complex with pepstatin A at 2.05 and 2.5 A resolution, respectively. With the structure of Sap1, we have completed the set of structures of isoenzyme subgroup Sap1-3. Of subgroup Sap4-6, the structure of the enzyme Sap5 is the first structure that has been described up to now. This facilitates comparison of structural details as well as inhibitor binding modes among the different subgroup members. Structural analysis reveals a highly conserved overall secondary structure of Sap1-3 and Sap5. However, Sap5 clearly differs from Sap1-3 by its electrostatic overall charge as well as through structural conformation of its entrance to the active site cleft. Design of inhibitors specific for Sap5 should concentrate on the S4 and S3 pockets, which significantly differ from Sap1-3 in size and electrostatic charge. Both Sap1 and Sap5 seem to play a major part in superficial Candida infections. Determination of the isoenzymes' structures can contribute to the development of new Sap-specific inhibitors for the treatment of superficial infections with a structure-based drug design program.
Mots-clé
Apoenzymes/antagonists & inhibitors, Apoenzymes/chemistry, Aspartic Endopeptidases/antagonists & inhibitors, Aspartic Endopeptidases/chemistry, Binding Sites, Candida albicans/enzymology, Crystallization, Crystallography, X-Ray, Fungal Proteins/antagonists & inhibitors, Fungal Proteins/chemistry, Pepstatins/chemistry, Recombinant Proteins/antagonists & inhibitors, Recombinant Proteins/chemistry
Pubmed
Web of science
Création de la notice
02/10/2009 17:33
Dernière modification de la notice
20/08/2019 13:59